Table 2 Prognostic risk model for endometrial cancer
From: A novel risk score system of immune genes associated with prognosis in endometrial cancer
Name | Coef | HR; 95% CI | P value |
|---|---|---|---|
HTR3E | 0.513 | 1.67 (1.34–2.09) | 0.000 |
CBLC | 0.015 | 1.02 (1.01–1.02) | 0.000 |
TNF | 0.034 | 1.03 (1.01–1.05) | 0.000 |
PSMC4 | 0.004 | 1.00 (1.00–1.01) | 0.003 |
TRAV30 | 0.110 | 1.12 (1.04–1.20) | 0.004 |
PDIA3 | − 0.004 | 1.00 (0.99–1.00) | 0.004 |
FGF8 | 0.020 | 1.02 (1.01–1.03) | 0.006 |
PDGFRA | 0.029 | 1.03 (1.01–1.05) | 0.010 |
ESRRA | 0.048 | 1.05 (1.01–1.09) | 0.013 |
SBDS | 0.016 | 1.02 (1.00–1.03) | 0.016 |
CRHR1 | 0.162 | 1.18 (1.02–1.35) | 0.021 |
LTA | − 0.819 | 0.44 (0.21–0.93) | 0.031 |
NR2F1 | 0.019 | 1.02 (1.00–1.04) | 0.032 |
TNFRSF18 | − 0.028 | 0.97 (0.95–1.00) | 0.038 |
VIPR2 | − 1.231 | 0.29 (0.08–1.09) | 0.068 |
LGR5 | 0.007 | 1.01 (1.00–1.01) | 0.068 |
IL13RA2 | 0.024 | 1.02 (1.00–1.05) | 0.071 |
PTN | 0.005 | 1.01 (1.00–1.01) | 0.080 |
BACH2 | − 0.401 | 0.67 (0.42–1.07) | 0.090 |
GHR | 0.816 | 2.26 (0.86–5.96) | 0.099 |
ADCYAP1R1 | − 0.047 | 0.95 (0.90–1.01) | 0.133 |
ORM1 | − 0.027 | 0.97 (0.94–1.01) | 0.148 |